MGMT and central nervous system cancer: MGMT is a DNA repair enzyme that removes alkyl groups from the O6 position of guanine, a site commonly damaged by alkylating chemotherapeutic agents like temozolomide (TMZ) so gliomas with a methylated MGMT promoter, the reduced repair capability increases the efficacy of alkylating agents, making chemotherapy more effective (16–19).